IL4I1, a metabolic immune checkpoint that activates the aryl hydrocarbon receptor (AHR) through the generation of indole metabolites and kynurenic acid, has been shown to promote cancer cell mobility and metastasis and to suppress anti-tumor immunity32. The gene discussed is AHR; the disease is neoplasm.